Galena Biopharma

Aug 14, 2018

RXi Pharmaceuticals Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights

Jan 24, 2018

RXi Pharmaceuticals Regains Compliance with NASDAQ Listing Requirements

Dec 01, 2017

This Morning's Technical Outlook on Biotech Stocks -- DelMar Pharma, Galena Biopharma, Heat Biologics, and Idera Pharma

Nov 08, 2017

RXi Pharmaceuticals Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights

Oct 02, 2017

SELLAS Enters into a Clinical Trial Collaboration and Supply Agreement with Merck & Co., Inc., Kenilworth, N.J., USA

Sep 18, 2017

Stock Performance Review on Biotech Industry -- Galena Biopharma, Idera Pharma, Ignyta, and Jaguar Health

Aug 11, 2017

The Rosen Law Firm, P.A. Announces Proposed Settlement with Remaining Defendants in Galena Biopharmaceutical Securities Litigation

Aug 10, 2017

RXi Pharmaceuticals Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights

Aug 03, 2017

RXi Pharmaceuticals Granted 180-Day Extension by Nasdaq Stock Market to Regain Compliance with Listing Requirements

Jun 12, 2017

Breakfast Technical Briefing on Biotech Stocks -- CEL-SCI, Amicus Therapeutics, Galena Biopharma, and Cleveland BioLabs